Our analysis found that ischaemic patients with both higher serum TIMP‐1 (≥184.2 ng/mL) and MMP‐9 (≥462.6 ng/mL) levels had higher risk of post‐stroke cognitive impairment. This evidence concerns the gene MMP9 and stroke disorder.